Latest net income for VRAY: $-110M, below the Healthcare sector average of $16B.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2023
Trailing 12 months ending Mar 2023
Loading...
Loading...
ViewRay (VRAY) currently reports a net income of $-110M as of March 2023. That compares with $-110M in the prior-year period — down 6.3% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore ViewRay's net income history and peer comparisons.
ViewRay's net income decreased from $-110M to $-110M — a 6.3% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
ViewRay's net income of $-110M is lower than the Healthcare sector average of $16B. That is roughly 100.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
ViewRay reported $-110M in net income as of March 2023. That compares with $-110M in the prior-year period — down 6.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current net income of $-110M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for ViewRay, and consider following VRAY for alerts when major investors trade the stock.